11:44 AM EDT, 10/18/2024 (MT Newswires) -- Glenview Capital, under a non-disclosure agreement with CVS, has expressed support for a "prompt" evolution of the CVS Health ( CVS ) board following the resignation of Chief Executive Karen Lynch.

The firm said it believes that strengthening the board with industry experts and fresh perspectives is essential for improving the company's culture, governance, and leadership.

CVS shares fell 9.2% in recent trading.

Price: 57.84, Change: -5.83, Percent Change: -9.16